RAPP
Rapport Therapeutics, Inc.
39.70$
-2.0%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.9% | 97.1% | 98.4% | 97.3% | |
| 98.6% | 45.1% | 18.0% | 10.3% | |
| 98.6% | 94.9% | 96.9% | 95.7% | |
| 38.3% | 116.5% | 3.0% | 5.4% | |
| 5.3% | 5.7% | 2.8% | 3.7% | |
| – | 0.4% | 0.2% | 0.5% | |
| 4.6% | 1.6% | 0.6% | 0.8% | |
| 61.7% | -16.5% | 97.0% | 94.6% | |
| -33.7% | -29.2% | -39.3% | -45.9% | |
| 63.7% | 11.6% | 6.6% | 9.2% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.